Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Breakthrough Molecular Detection Platform Delivers Best-In-Class Accuracy without Need for Target Amplification

By LabMedica International staff writers
Posted on 18 Oct 2023

A disruptive new platform that operates with a combination of unprecedented speed and accuracy promises to revolutionize molecular detection and emerge as a new gold standard tool to empower clinical decision-making. More...

VedaBio (San Diego, CA, USA) has harnessed the immense potential of CRISPR technology to create CRISPR Cascade, a game-changing platform that's the outcome of integrating engineering and biology. The CRISPR Cascade eliminates the requirement for target amplification yet offers the same level of accuracy as PCR tests, delivering analytical results in less than a minute. Unlike traditional DNA/RNA amplification methods like PCR, where increasing the complexity of the assay by multiplexing complicates things, CRISPR Cascade eliminates these constraints. It allows for extremely simple, highly multiplexed tests without sacrificing signal quality or encountering cross-reactivity. The platform offers a blend of high sensitivity, precision, and nearly immediate results, opening up a wide range of new possibilities.

One of the standout features of the CRISPR Cascade is its unprecedented speed and processing power, which facilitate almost instant results best-in-class accuracy. This is made possible by the use of two specific ribonucleoproteins (RNPs): the first, known as RNP1, identifies the target genetic sequence, while the second, RNP2, carries out an additional function, like signal amplification, for example. In contrast to existing DNA amplification methods like PCR, where combining multiple primers can reduce the assay's sensitivity and specificity, CRISPR Cascade can pool different RNP1s, allowing for massive multiplexing without any loss in signal-to-noise ratio (SNR) or cross-reactivity issues. This means that creating new tests or target applications becomes a matter of simple RNP1 adjustments. These modifications are compatible with various types of reporting mechanisms, including fluorescence and colorimetric methods. Thanks to its robust, room-temperature chemistry that is highly compatible with microfluidics, CRISPR Cascade enables almost immediate molecular detection along with significant multiplexing capabilities.

“With the CRISPR Cascade reaction, we have unlocked the true power of CRISPR with a platform that delivers near-instant molecular detection of highly multiplexed analytes with best-in-class accuracy, all without the need for target amplification,” said Anurup Ganguli, PhD, Co-Founder and Chief Executive Officer of VedaBio. “We believe it is poised to emerge as a future gold standard for molecular detection, empowering major advances across multiple applications including research and industrial tools, diagnostics and therapeutics.”

Related Links:
VedaBio 


New
Gold Member
Automatic Hematology Analyzer
DH-800 Series
Collection and Transport System
PurSafe Plus®
New
Automatic Chemiluminescence Immunoassay Analyzer
Shine i2000
New
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.